Affinity selection mass spectrometry speeding drug discovery

被引：10

作者：

Prudent, Renaud ^{[1
]}

Lemoine, Hugues ^{[1
]}

Walsh, Jarrod ^{[2
]}

Roche, Didier ^{[1
]}

机构：

[1] Edelris, Bioparc,Bioserra 1 Bldg, Lyon, France

[2] AstraZeneca, R&D BioPharmaceut, Discovery Sci, High Throughput Screening,Hit Discovery, Alderley Pk, England

来源：

DRUG DISCOVERY TODAY | 2023年 / 28卷 / 11期

关键词：

af finity selection mass spectrometry; hit identi fication; drug discovery; COMBINATORIAL LIBRARIES; HIT IDENTIFICATION; LIGANDS; CHROMATOGRAPHY; TECHNOLOGIES; INHIBITORS; EVOLUTION; MAGMASS; SITE; MS;

D O I：

10.1016/j.drudis.2023.103760

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Affinity selection mass spectrometry (AS-MS) has gained momentum in drug discovery. This review summarizes how this technology has slowly risen as a new paradigm in hit identification and its potential synergy with DNA encoded library technology. It presents an overview of the recent results on challenging targets and perspectives on new areas of research, such as RNA targeting with small molecules. The versatility of the approach is illustrated and strategic drivers discussed in terms of the experience of a small-medium CRO and a big pharma organization.

引用

页数：8

共 50 条

[31] Affinity selection-mass spectrometry for the discovery of pharmacologically active compounds from combinatorial libraries and natural products
Muchiri, Ruth N.
van Breemen, Richard B.
JOURNAL OF MASS SPECTROMETRY, 2021, 56 (05):
[32] Use of affinity selection mass spectrometry to screen organic compounds of diverse structures for drug leads.
Yang, HJ
Cheng, XH
Bakhoum, A
Hajduk, P
Lico, I
Voorbach, M
Dandliker, P
Schurdak, M
Gao, L
Buko, A
Miesbauer, L
Schmitt, R
Martin, Y
Beutel, B
Burns, D
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U99 - U99
[33] pyBinder: Quantitation to Advance Affinity Selection-Mass Spectrometry
Brown, Joseph S.
Lee, Michael A.
Vuong, Wayne
Loas, Andrei
Pentelute, Bradley L.
ANALYTICAL CHEMISTRY, 2025, 97 (07) : 3855 - 3863
[34] The Role of Mass Spectrometry in Biopharmaceutical Drug Discovery and Development
Edwards, Ian John
SPECTROSCOPY, 2018, 33 (04) : 36 - 40
[35] Biochemical applications of mass spectrometry in pharmaceutical drug discovery
Geoghegan, KF
Kelly, MA
MASS SPECTROMETRY REVIEWS, 2005, 24 (03) : 347 - 366
[36] Perspectives on Bioanalytical Mass Spectrometry and Automation in Drug Discovery
Janiszewski, John S.
Liston, Theodore E.
Cole, Mark J.
CURRENT DRUG METABOLISM, 2008, 9 (09) : 986 - 994
[37] Imaging mass spectrometry: fundamentals and applications to drug discovery
Rubakhin, SS
Jurchen, JC
Monroe, EB
Sweedler, JV
DRUG DISCOVERY TODAY, 2005, 10 (12) : 823 - 837
[38] Integrating mass spectrometry into membrane protein drug discovery
Weinglass, AB
Whitelegge, JP
Kaback, HR
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (05) : 589 - 599
[39] Advances in MALDI Mass Spectrometry within Drug Discovery
Cornett, Dale S.
Scholle, Michael D.
SLAS DISCOVERY, 2017, 22 (10) : 1179 - 1181
[40] Drug discovery - Drug discovery: Affinity and beyond
Janjic, N
BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1998, 11 (02): : 28 - 28

← 1 2 3 4 5 →